Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-08-19
1996-03-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 551, A61K 3170
Patent
active
054986060
ABSTRACT:
The cells of the coverings and linings of internal human and animal tissues, organs and body cavities subject to trauma, such as surgery, may be protected against exfoliation or destruction by the topical application or injection of effective amounts of chondroitin sulfate prior to or during the trauma. Preferably, the chondroitin sulfate is used in physiological solutions in concentrations of about 40 to 55 weight percent, and may be used as a surgical irrigating solution. Intraarticular injection of such chondroitin sulfate solutions into human and animal joints having degenerative joint conditions protects the joint cells, reduces aseptic inflammation and/or prevents further degeneration of cartilage tissue. Solutions for preserving human and animal cells and tissues in vitro for later in vivo use have extended storage life when chondroitin sulfate is added to such storage solutions in effective amounts such as about 1 to 20 weight percent of the storage solution.
REFERENCES:
patent: 1950100 (1934-03-01), Crandall, Jr.
patent: 4141973 (1979-02-01), Balazs
patent: 4486416 (1984-12-01), Soll et al.
Kanai, Chemical Abstracts, vol. 87 (19) (1977) No. 146448v.
Langham, M. E., et al., "The Interaction of Collagent and Mucopolysaccharides," Macromolecular Organization of a Connective Tissue, 157-84 (Langham, M. E. ed., Johns Hopkins Press: 1968).
"HEALON.RTM." Product Monograph, Pharmacea Laboratories, Piscataway, NJ (1980).
Balazs and Gibbs, "The Rheological Properties and Biological Function of Hyaluronic Acid," Chemistry and Molecular Biology of the Intercellular Matrix, (E. Balazs ed. 1970).
Saito, M. and Kano, K., "Effect of Chondroitin Sulfate on Spondylosis Deformans," Rinsho Geka (Clinical Surgery), 12(10):807-10 (1957).
Takematsu, Y., et al., "Long-Term Administration of Sodium Chondroitin Sulfate (Chondron) for the Treatment of Some Orthopedic Diseases," Ringai (Clinical Surgery, 16(5):443-47 (1961).
Rydell, M. and Balazs, E. A., "Effect of Intra-articular Injection of Hyaluronic Acid on the Clinical Symptoms of Osteoarthritis and on Granulation Tissue Formation," Clinical Orthopedics and Related Research, 80:25-32 (Oct. 1971).
Drugs in Japan: Ethical Drug Edition 1975 (and translation of cover, title page, rear of title page, p. 22 and p. 216).
Harrison Sol E.
Soll David B.
Peselev Elli
Robinson Douglas W.
LandOfFree
Protection of human and animal cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protection of human and animal cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection of human and animal cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100020